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Summary  In  the  past  10  years,  stent  implantation  has  become  a  real  alternative  to  surgery  in
the management  of  both  native  and  recurrent  coarctation  of  the  aorta  in  adolescents  and  adults.
The purpose  of  this  report  is  to  provide  a  detailed  review  of  stent  implantation  techniques,
including  pre-procedure  imaging,  technical  aspects  and  results.  The  success  rate  is  usually  high
(around 90%),  and  the  procedure  results  in  an  increase  in  the  diameter  of  the  coarcted  segment,
a decrease  in  the  transisthmic  systolic  gradient  and  a  better  control  of  systemic  hypertension.
The most  serious  complication,  rupture  of  the  aorta,  can  be  fatal,  but  is  rare  (<  2%).  Aneurismal
dilatation  is  another  potential  problem  that  occurs  in  around  5—9%  of  cases,  and  may  be  related
to overstretching  and  pre-stent  dilatation,  so  these  should  be  avoided.  It  is  necessary  to  point
out that  most  of  these  aneurysms  are  small  and  conservatively  managed.  Restenosis  is  another
complication  that  may  result  from  neointimal  proliferation,  stent  recoil  and  stent  fracture.
Balloon  dilatation  with  a  higher  inﬂating  pressure  or  repeat  stent  implantation  is  proposed
herein. A  comparison  with  surgery  is  also  discussed,  and  a  follow-up  protocol  is  proposed  to
capture late  complications.  Owing  to  good  initial  and  intermediate  results,  stent  implantation  is
nowadays considered  as  a  ﬁrst-line  therapy  in  most  adolescents  and  adults  with  (re)coarctation
of the  aorta.
©  2011  Elsevier  Masson  SAS.  All  rights  reserved.
Abbreviations: BIB, balloon-in-balloon; CI, conﬁdence interval; CT, computed tomography; MRI, magnetic resonance imaging; OR, odds
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Résumé  La  mise  en  place  de  stent  est  devenue  depuis  une  dizaine  d’année  une  véritable
alternative  thérapeutique  à  la  chirurgie  dans  le  traitement  des  coarctations  de  l’aorte  chez
l’adolescent  ou  l’adulte.  Le  propos  de  cet  article  est  une  revue  détaillée  de  cette  technique
comportant  l’imagerie  avant  implantation,  les  aspects  techniques  et  les  résultats.  Le  taux  de
réussite avoisine  les  90  %  avec  une  augmentation  du  diamètre  coarctée,  une  diminution  du
gradient trans-isthmique  et  un  meilleur  contrôle  de  l’HTA.  La  complication  principale  est  la
rupture de  l’aorte  (<  2  %)  qui  peut  être  fatale.  Le  développement  d’un  anévrysme  est  une  autre
complication  (5—9  %)  qui  peut  être  liée  à  une  pré-  ou  sur-dilatation  qui  doivent  être  proscrites.
Il est  nécessaire  de  signaler  que  la  plupart  des  ces  anévrismes  sont  minimes  et  ne  nécessitent
aucun geste  complémentaire.  La  resténose  (recoarctation)  est  une  autre  complication  qui  peut
résulter d’une  prolifération  intimale,  d’un  « recoil  »,  ou  d’une  fracture  de  stent.  Dans  ces  cas,
une dilatation  avec  un  ballon  à  haute  pression  voire  un  re-stenting  peuvent  être  réalisés.  Une
comparaison  avec  la  chirurgie  est  aussi  abordée  et  un  protocole  de  suivi  post-implantation
proposé. En  fait,  en  raison  des  bons  résultats  immédiats  et  à  distance,  la  mise  en  place  d’un  stent
est aujourd’hui  proposée  souvent  en  première  intention  dans  le  traitement  de  la  coarctation
de l’aorte  chez  l’adolescent  et  l’adulte.
© 2011  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Tackground
lthough  the  optimal  treatment  of  coarctation  of  the  aorta
emains  arguable,  with  no  real  randomized  controlled  trials
omparing  a  percutaneous  approach  to  surgical  repair,  the
ndovascular  treatment  of  both  native  and  recurrent  coarc-
ation  has  gained  a  widespread  acceptance  since  the  mid
990s,  especially  in  adolescents  and  adults  [1].  As  has  been
bserved  with  other  balloon  dilatation  techniques,  there
as  been  a  recent  shift  from  balloon  angioplasty  alone  to
tent  implantation.  Balloon  dilatation  can  injure  the  intima
nd  part  of  the  media,  so  although  the  vessel  diameter
s  increased,  ﬁbrous  scar  tissue  can  form  over  a  period
f  months  [2,3]  that  may  result  in  recoil,  restenosis  and
neurismal  disease.  Advantages  of  using  a  stent  are  the
adial  support  to  the  vessel  wall  and  the  apposition  of  the
orn  vessel  intima  to  the  media  with  the  possibility  to  per-
orm  redilatation  (especially  in  young  patients)  with  no  need
or  oversizing  to  avoid  major  transmural  tears  [4—6].
The  purpose  of  this  report  is  to  provide  a  detailed
eview  of  balloon-expandable  stents  for  the  transcatheter
reatment  of  adolescents  and  adults  with  (re)coarctation,
ncluding  pre-procedure  imaging,  technical  aspects  of  the
echnique,  results  and  complications.  A  comparison  with
urgery  is  also  discussed,  and  a  follow-up  protocol  is
roposed.
re-procedure imaging
t  is  well  established  that  Doppler  echocardiography  can  be
sed  to  diagnose  and  estimate  the  severity  of  coarctation
f  the  aorta.  However,  in  adults,  adequate  imaging  of  the
sthmic  anatomy  is  not  as  good  as  in  infancy.  Difﬁculties  can
e  encountered  in  patients  in  whom  the  distance  between
he  ultrasound  probe  and  the  descending  aorta  is  too  large
nd  in  whom  image  resolution  is  too  poor.  Similarly,  gradi-
nt  measurements  by  continuous-wave  Doppler  may  not  be
btainable  in  all  patients.
O
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aMRI is  a  good  alternative,  and  a  reliable  non-invasive
ethod  to  depict  the  aortic  arch  anatomy.  Both  spin-  and
radient-echo  sequences,  especially  in  the  oblique  plane,
an  be  used  to  demonstrate  the  arch  anatomy  and  pro-
ide  accurate  measurements  of  the  aorta  [7].  Cine  MRI  can
e  used  to  depict  lucent  jets  of  high-velocity  ﬂow  through
he  site  of  coarctation,  with  jet  length  correlating  to  the
ngiographic  severity  of  coarctation  [8,9]. Phase-contrast
equences  make  it  possible  to  calculate  the  peak  systolic
elocity  gradient  (similarly  to  the  echo  Doppler  technique
sing  the  Bernoulli  formula)  and  blood-ﬂow  quantiﬁcation.
n  increase  in  aortic  blood  ﬂow  at  the  level  of  diaphragm,  in
omparison  to  that  just  below  the  coarctation  site,  reﬂects
he  amount  of  blood  ﬂow  through  the  collateral  vessels.  Of
articular  importance  to  the  interventionist  is  the  choice  of
he  balloon/stent.  For  this,  various  calculations  have  to  be
ade:  narrowest  diameter  at  the  coarctation  site  (coarcted
egment);  the  isthmic  diameter  just  above  the  transverse
rch  (proximal  to  the  origin  of  the  left  subclavian  artery)
nd  the  diameter  of  the  thoracic  aorta  at  the  level  of  the
iaphragm  [10].
CT can  also  be  used  to  calculate  these  aortic  diameters,
nd  is  recommended  in  patients  with  claustrophobia,  metal-
ic  clips  or  thoracic  prostheses  (that  may  cause  artefacts  on
RI)  or  pacemakers/deﬁbrillators.  Both  MRI  and  CT  tech-
iques  make  it  possible  to  obtain  contrast-enhanced  imaging
nd  3D  reconstructions  that  are  very  useful  for  the  cardiol-
gist,  providing  images  very  similar  to  those  from  classic
ngiography.  Similar  information  can  also  be  obtained  from
ardiac  catheterization,  but  this  technique  is  mainly  used
or  interventional  procedures.
he stent implantation techniquewing  to  the  possibility  of  chest  pain  during  inﬂation  and
atient  movement  [5,11], the  procedure  is  usually  per-
ormed  under  general  anaesthesia.  Patients  are  often  given
ntibiotic  prophylaxis  and  heparin  100  IU/kg  body  weight
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(maximum  5000  IU)  [12], administered  before  the  introduc-
tion  of  sheath.  Heparin  is  neither  reversed  at  the  end  of  the
procedure  nor  continued  after  the  procedure.
The  aorta  is  usually  entered  retrogradely,  using  a
guidewire  from  the  femoral  artery.  The  aortic  pressures  are
recorded  in  the  thoracic  aorta  before  crossing  the  narrowest
segment  with  the  angiographic  catheter  (classically  a  pigtail
catheter).  Sometimes,  it  may  be  useful  to  employ  a  straight
catheter  (e.g.,  a  right  Judkins  catheter  with  hydrophilic
guidewire;  Terumo)  to  cross  a  very  tight  lesion.  Once  the
coarctation  has  been  crossed,  the  aortic  pressure  is  recorded
again,  allowing  the  calculation  of  the  peak-to-peak  systolic
gradient  across  the  coarcted  segment.  This  pressure  gradi-
ent  is  essential,  and  when  the  peak-to-peak  systolic  gradient
is  >  20  mmHg,  this  deﬁnes  (re)coarctation  of  the  aorta  [5].
However,  this  pressure  gradient  can  be  less  important  due  to
general  anaesthesia  or  the  development  of  important  collat-
eral  vessels.  Aortography  is  then  performed  to  demonstrate
the  anatomy  of  the  aortic  arch  and  coarctation,  and  to  calcu-
late  the  aortic  dimensions  reported  above  [12]. Angiography
is  usually  performed  in  the  left  aortic  oblique  projection
(30—60◦)  [3,12], in  lateral  and  anteroposterior  projections.
When  the  coarcted  segment  is  nearly  atretic,  brachial
arterial  access  is  obtained  for  aortic  arch  angiograms  and  to
cross  the  coarctation  with  a  guidewire  [4,11]. After  imag-
ing,  and  if  the  patient  fulﬁls  the  classic  criteria,  stent
implantation  can  be  used  as  an  alternative  to  classic  bal-
loon  angioplasty  alone.  Owing  to  the  use  of  large  introducing
sheaths,  vascular  closure  devices  (e.g.,  Perclose  AT;  Abbott
Vascular  Devices)  are  placed  before  dilatation  as  pre-closing
devices  to  avoid  bleeding  and  achieve  effective  haemostasis
after  the  procedure  [4].
The  choice  of  stent  diameter  and  length  is  of  major
importance  for  this  technique.  The  stent  must  cover  the
coarcted  segment  without  protrusion  into  the  left  subclavian
artery.  Stent  diameter  is  selected  based  on  the  diameter  of
the  proximal  aorta  —  mainly  transverse  or  distal  arch  diam-
eter  —  or  1—2  mm  larger  [4,5]. The  stent  diameter  must  not
exceed  the  diameter  of  the  descending  aorta  at  the  level  of
the  diaphragm,  in  order  to  avoid  aneurysm  formation  or  rup-
ture.  Another  approach  is  to  use  the  average  of  the  aortic
isthmus  (or  transverse  aortic  arch)  and  the  descending  aorta
at  the  level  of  diaphragm.  The  ratio  of  expanded  stent  diam-
eter  to  that  of  coarcted  segment  is  frequently  around  2—3.5
and  should  be  <  3.5  [13].
In order  to  form  a  rigid  track  for  stabilization  of  the  bal-
loon/stent  during  deployment,  a  Rosen  (Cook,  Bloomington,
USA)  or  exchange  Amplatz  superstiff  guidewire  (Meditech)
is  used,  with  the  tip  placed  above  the  coarcted  segment  in
the  ascending  aorta  or  the  right  subclavian  artery.  Over  that
wire,  the  delivery  sheath  and  its  dilator  are  then  advanced
to  the  transverse  aorta.  A  balloon-expandable  stent  is  hand
crimped  down  onto  the  balloon,  which  is  a  little  bit  longer
than  the  stent.  This  can  be  performed  by  a  piece  of  umbili-
cal  tape  looped  around  the  stent  and  the  balloon  and  pulled
at  both  ends  to  help  tighten  the  stent  onto  the  balloon.
The  dilator  is  then  removed,  and  the  balloon—stent  com-
plex  is  advanced  within  the  sheath  to  the  coarctation  site
and  a  little  bit  further.  The  sheath  is  then  withdrawn,  expos-
ing  the  balloon—stent  complex,  which  is  correctly  placed
across  the  stenotic  lesion.  The  position  is  usually  checked
by  angiography  through  the  sheath  before  inﬂation.  For
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alloon-expandable  stents,  deployment  is  realized  by  inﬂa-
ion  of  the  balloon  catheter  using  one  or  two  inﬂation
evices  with  a  20  or  30  mL  syringe  (especially  for  larger  bal-
oons),  and  without  exceeding  the  maximal  pressure  value
ecommended  by  the  manufacturer  [12]. Inﬂation  lasts  for  a
ew  seconds.  Sometimes,  right  ventricular  pacing  (or  rarely
denosine  infusion)  is  employed  to  facilitate  stent  place-
ent  during  inﬂation  [14]. If  a  waist  or  any  signiﬁcant
ressure  gradient  persists,  further  dilatation  is  usually  per-
ormed  using  a  higher-pressure  balloon  catheter  [15].
The stent  implantation  procedure  is  classically  consid-
red  successful  if  the  residual  gradient  is  <  10  mmHg,  with
n  improvement  in  diameter  to  >  90%  of  the  normal  adja-
ent  aortic  arch  vessel  [15—18]. The  success  rate  is  >  90%
14,16,18,19],  generally  with  no  residual  gradient,  whereas
alloon  dilatation  alone  usually  results  in  persistent  gradi-
nt.  As  proposed  by  Chessa  et  al.  [12], it  is  recommended
ot  to  ﬂare  the  ends  of  the  stent  with  a balloon  of  a  larger
ize  to  model  it  to  the  dilated  post-stenotic  segment  because
here  is  no  clear  evidence  of  any  signiﬁcant  beneﬁt,  but  a
eal  risk  of  stent  migration  or  aneurysm  formation.
If  the  haemodynamic  and  angiographic  results  are  cor-
ect,  the  sheath  is  removed,  and  closure  of  the  femoral
rtery  is  realized  with  a  vascular  occluding  system.  The
lassic  predilatation  technique  is  no  longer  recommended
ecause  it  can  make  it  more  difﬁcult  to  obtain  good  contact
ith  the  stenotic  segment,  and  direct  stenting  is  now  rec-
mmended  to  decrease  the  risk  of  embolization  [19].
If the  patient  is  on  antihypertensive  drug  treatment,  this
s  usually  continued  for  1—4  months,  with  restriction  for
ompetitive  sport  or  strenuous  exercise.  If  the  patient  is
ot  taking  any  drug  before  the  procedure,  antihypertensive
edication  for  1  month  to  avoid  barotraumatic  lesions  has
een  proposed  [16], but  this  is  not  commonly  used.  In  around
7%  of  cases,  stents  may  need  to  overlap  arch  vessels  [16].
his  can  be  achieved  without  compromising  distal  perfusion
ue  to  the  availability  of  open-cell  design  stents.  In  theory,
hese  allow  balloon  angioplasty  through  the  cell  into  adja-
ent  arch  branches.  Such  patients  should  receive  long-term
nti-platelet  therapy.
omplications
he  most  serious  complication  of  stenting  is  rupture  of  the
orta,  which  although  rare,  may  lead  to  severe  haemoth-
rax  with  circulatory  collapse  and  death  [12,15,20]. This
as  been  reported  to  occur  in  1.6%  of  565  procedures  in
 large  multicentre  study  [16]. The  risk  factors  for  aor-
ic  wall  complications  (dissection  and  intimal  tear)  in  this
tudy  included:  performing  pre-stent  balloon  angioplasty
odds  ratio  [OR]  4.18);  location  of  the  coarctation  at  the
bdominal  aorta  compared  to  the  isthmus  (OR  5.74);  and
ge  >  40  years  (OR  2.95)  [16]. Use  of  a  covered  stent  at
mplantation  has  been  proposed  to  reduce  the  risk  of  aortic
all  complications.  However,  there  is  no  evidence  of  bet-
er  results  in  comparison  with  bare  stents,  but  there  is  an
ncreased  risk  of  occlusion  of  side  branches  [16]. Despite
his,  direct  availability  of  covered  stents  in  the  catheteriza-
ion  laboratory  is  a  prerequisite  for  interventional  treatment
f  coarctation  [15].
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Table  1  Dimensions  of  some  of  the  available  stents.
Stent  expansion
diameter  (mm)
Stent  length
(mm)
CP  bare/covered
stenta
12—24  16,  22,  28,
34,  39,  45
IntraStentTM
MegaTM LDb
9—18  16,  26,  36
IntraStentTM MaxTM
LDb
16—25  16,  26,  36
Palmaz® XLc 14—25  40,  50
Adventa  V12
(covered)d
12—16  (up  to
22)
29,  41,  61
a NuMED, Hopkinton, NY, USA.
b EV3, Plymouth, MN, USA.
c Johnson and Johnson, Cordis, Roden, The Netherlands.
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Aneurismal  formation  is  another  potential  complication
f  stenting.  However,  deﬁnitions  vary  between  minimal
ulging  with  >  3—3  mm  dyskinesis  of  the  aortic  wall  [20,21];
 10%  expansion  of  the  aorta  outside  the  stent  [13,22];
ilatation  of  the  aorta  at  the  dilatation  site  exceeding  120%
14]  or  150%  [17,21]  of  the  diameter  of  the  aorta  at  the  level
f  the  diaphragm.  Thus,  the  real  incidence  of  aneurysms
s  unknown,  but  is  probably  around  5—9%  [13,14,17]. The
ascular  causes  of  aneurysm  include:  damage  to  the  vessel
all  by  the  balloon  with  overstretching;  technical  difﬁ-
ulties;  and  aortic  cystic  medial  necrosis  with  decreased
ensity  of  elastin  in  the  arterial  wall  and  increase  collagen
ontent  as  underlying  anomalies.  In  fact,  special  precau-
ions  have  to  be  taken  to  avoid  manipulating  the  tip  of
he  catheter  or  guidewire  over  the  recently  dilated  aor-
ic  segment.  In  the  experience  of  Mahadevan  et  al.  [20],
o  predictive  factors  could  be  established  for  aneurysm
ormation,  including  age,  initial  systolic  blood  pressure,
oarcted  dimension,  pre-  or  post-stenting  gradient,  native
r  recoarctation,  or  type  of  stent.  Similar  ﬁndings  have
een  reported  in  a  multicentre  study  by  Forbes  et  al.  [13].
n  addition,  no  signiﬁcant  difference  in  the  incidence  of
ortic  wall  injury  could  also  be  found  according  to  the  vol-
me  of  cases  (<  25  or  >  25)  or  the  centre  [14]. However,  a
alloon-to-coarctation  ratio  >  3.5  at  initial  procedure  and
re-stent  angioplasty  have  both  been  associated  with  more
ortic  wall  injury  [13], and  should  therefore  be  avoided.
t  is  necessary  to  point  out  that  the  majority  of  these
neurysms  are  small  and  conservatively  managed.  Only  large
neurysms  require  the  use  of  a  covered  stent  or  surgical
esection.
Another  potential  complication  is  stent  migration  and
mbolization  during  the  procedure.  Most  commonly,  the
tent  slips  down  inside  the  thoracic  aorta,  frequently  with-
ut  clinical  consequence,  more  rarely  proximally  [15]. The
ause  of  stent  migration  can  be  related  to:  an  oversized
alloon  (>  2  mm  larger  than  the  proximal  aorta),  an  under-
ized  balloon  catheter,  or  balloon  rupture  [16]. The  latter
as  been  reported  more  frequently  with  the  old  P8  Pal-
az  stent  [16]. Usually,  the  stent  does  not  need  to  be
epositioned,  but  if  this  is  necessary,  the  stent  can  be  mobi-
ized  within  the  aorta  using  a  balloon  catheter,  and  fully
xpanded  at  the  most  appropriate  site.  Rarely,  the  stent
an  become  trapped  in  the  aorta  or  femoral  artery,  in
hich  case,  it  can  be  captured  with  a  lasso  and  pulled  back
nto  a  sheath  [19]. In  case  of  malposition,  a  second  pro-
edure  is  performed,  which  usually  results  in  a  successful
utcome.
Restenosis  is  another  possible  issue  after  stent  place-
ent,  but  is  less  frequent  than  after  balloon  angioplasty
lone,  where  it  has  been  reported  to  occur  in  13—31%  of
ases  [3].  Restenosis  has  been  reported  after  stenting  in
.7%  of  patients  in  a  study  of  578  patients  [13], and  in
2%  in  a  large  multicentre  study  in  302  patients,  although
n  this  study,  if  planned/staged  repeat  interventions  were
xcluded,  the  restenosis  rate  was  only  4%  [14]. This  is
learly  the  main  reason  for  using  stent  instead  of  balloon
ngioplasty  alone  in  the  percutaneous  treatment  of  coarc-
ation.  The  re-coarctation  may  result  from  re-modelling  of
he  coarcted  segment  and  development  of  neointimal  pro-
iferation,  stent  fracture,  stent  recoil  and  growth  [13,14].
ost  authors  have  proposed  re-dilation  of  the  stent  using  a
a
t
fd Atrium, Mijdrecht, The Netherlands.
alloon  catheter  with  a  higher  inﬂating  pressure  or  repeat
tent  implantation  in  the  case  of  stent  fracture  [12,13].
Cerebral  vascular  accident  is  rare  (<  1%),  and  can  be
elated  to  dissection  with  severe  neurological  injuries  due  to
olume  loss,  peripheral  embolism,  balloon  rupture  and  stent
igration  [16]. Another  possible  complication  is  paradoxi-
al  hypertension  following  the  procedure,  which  is  usually
reated  with  oral  -blockers  for  several  weeks.  Lastly,  prob-
ems  related  to  femoral  access  and  the  use  of  a  large  sheath
re  possible,  including  loss  of  femoral  pulse  with  risk  of
schaemia  and  haematoma  [15]. The  risk  of  these  can  be
educed  by  the  use  of  vascular  closure  devices.
hoice of stent and balloon catheter
he  choice  of  stent  and  balloon  catheter  depends  on
nstitutional  approach  and  individual  operator  preference.
ifferent  types  of  balloon-expandable  stents  and  balloon
atheters  can  be  used.  Stents  include  the  bare  or  cov-
red  Cheatham  Platinum  CP  stents  (NuMED;  Hopkinton,  NY,
SA),  Mega  LD  or  Max  LD  (EV3;  Plymouth,  MN,  USA),  Palmaz
Johnson  and  Johnson;  Cordis,  Roden,  The  Netherlands),  and
dventa  V12  (Atrium;  Mijdrecht,  The  Netherlands)  (Table  1).
ost  of  these  are  made  from  stainless  steel,  although  the
P  stent  is  made  from  an  alloy  of  90%  platinum  and  10%  irid-
um  [23]. Usually,  the  Palmaz  XL,  CP  eight-zig  or  EV3  stents
re  employed  for  longer  stenotic  segments.  Advantages  of
hese  stents  are:  a  good  expansibility  and  radial  force,  and
esser  shortening  than  the  Palmaz  8  series.  The  CP  eight-
ig  stent  is  quite  similar  to  the  Palmaz  XL,  but  has  a  better
adio-opacity  and  rounded  edges,  which  are  probably  less
raumatic  for  the  aortic  wall  [12].
Balloons  used  for  deployment  of  non-premounted  stents
nclude:  the  Z-Med/Z-Med  II  or  balloon-in-balloon  (BIB),  both
NuMED),  Opta-Pro  (Cordis)  balloons.  Many  teams  recom-
end  the  BIB  from  NuMED  [23], which  makes  it  possible  to
djust  the  stent  position  after  inﬂation  of  the  inner  balloon
nd  before  inﬂation  of  the  outer  balloon/stent  decreasing
he  risk  of  embolization  or  aneurysm  (Fig.  1).
Covered  stents  have  been  proposed  as  a  rescue  treatment
or  coarctation  aneurysm  or  stent-related  complications
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Figure 1. Adult native coarctation in an 18-year-old man. The coarctation diameter is 4.2 mm (A). Inﬂation of the inner BIB with a CP stent
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in  situations  such  as:  subatretic  coarctation,  native  coarc-(8Z34) (NuMED) (B). Inﬂation of the outer balloon (diameter 14 mm
is now 13 mm with no persistent gradient. BIB: balloon-in-balloon.
(fracture,  aneurysm  or  in-stent  thrombus)  and  initially
for  patients  at  risk  of  complications  due  to  complex
anatomy  (mainly  tortuosity)  or  advanced  age  [4,24]. The
most  widely  used  is  the  CP  covered  stent,  which  uses
a  gold  soldering  process  to  avoid  fracture  and  which  is
ﬁtted  with  a  covering  of  expanded  polytetraﬂuoroethy-
lene  (PTFE)  that  can  be  stretched  up  to  a  diameter  of
12—24  mm.  Its  implantation  is  similar  to  that  of  a  bare
stent,  but  requires  2—3  F  larger  sheaths  than  employed  for
the  introduction  of  the  sole  balloon  catheter.  An  alterna-
tive  covered  stent  is  the  Advanta  V12  stent  (Atrium).  The
self-expandable  covered  stent  (Valiant,  Medtronic)  (Fig.  2)
t
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Figure 2. A 38-year old patient with coarctation corrected at the age o
haemoptysis due to a small aneurysm at the inferior connection of the 
expandable stent (Valiant, Medtronic; diameter 38 mm, length 50 mm) (B
of a Palmaz stent (diameter 25 mm; length 40 mm).th 35 mm) (C). Control angiography (D). The coarctation diameter
an  also  be  used  to  exclude  an  aneurysm.  However,  this
tent  requires  a  larger  introducing  sheath  with  lesser  radial
orce  than  the  other  covered  stents,  so  is  not  frequently
mployed.
Superiority  of  covered  stents  over  bare  stents  in  terms  of
fﬁcacy,  aortic  diameter  expansion  and  gradient  reduction
as  not  been  proven,  but  there  is  a  real  risk  of  occlusion
f  side  branches.  However,  covered  stents  are  preferredation  associated  with  patent  ductus  arteriosus  (Fig.  3),
re)coarctation  combined  with  aneurysm  (Fig.  4)  and  recur-
ent  coarctation  after  PTFE  patch  [22,24].
f 10 years by a 10-mm prosthetic tube and suffering from recurrent
tube to the descending aorta (A). Aneurysm exclusion with a self-
). Full expansion of the previous stent is achieved by implantation
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Figure 3. Native coarctation combined with a small arterial duct in a 15-year-old boy. The diameter of coarctation is 13 mm  (A). Notice
the left-to-right shunt through the arterial duct. Control angiography after implantation of covered CP stent (8Z28) over a BIB (diameter
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e0 mm, length 30 mm) (NuMED) (B). There is no persistent left-to-ri
ardiovascular and haemodynamic results
nd changes
tenting  of  a  coarctation  induces  cardiovascular  mod-
ﬁcations.  The  commonly  reported  changes  include  an
ncrease  of  coarcted  diameter  from  6.9  mm  (1.3—15.5  mm)
o  13.8  mm  (5.5—23  mm),  a  decrease  in  pressure  gradient
rom  26  to  2  mmHg,  and  a  decrease  in  blood  pressure,  with
eduction  in  antihypertensive  drugs  and  no  hypertension  in
wo  thirds  of  patients  at  long-term  follow-up  [14]. In  addi-
ion,  Babu-Narayan  et  al.  [25]  have  shown,  in  an  MRI  study
erformed  10  months  after  stenting,  a  signiﬁcant  decrease
n  left  and  right  ventricular  mass,  enhanced  left  ventricular
unction,  and  a  reduction  in  the  size  and  blood  ﬂow  through
h
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igure 4. Recurrent coarctation after balloon angioplasty in a 14-yea
neurysm probably related to previous balloon dilatation. Control angiog
m BIB (length 25 mm, diameter 14 mm) (NuMED) (B). The diameter at t
xcluded by the covered stent with no residual gradient.hunt and no residual gradient is recorded. BIB: balloon-in-balloon.
ollaterals.  They  also  demonstrated  an  increase  in  ascending
orta  distensibility  [25]  that  may  reduce  the  classic  cardio-
ascular  risks  of  coarctation,  but  with  no  data  available  at
resent  for  late  outcomes.
It has  been  shown  that,  despite  early  surgical  repair,
oung  normotensive  adults  may  have  persistent  abnormali-
ies  of  the  vascular  reactivity,  with  increased  resistance  of
essels  anatomically  positioned  above  the  coarctation  [26].
his  has  emphasized  the  concept  of  peripheral  vasculopa-
hy  in  coarctation  that  could  probably  inﬂuence  late  systolic
ypertension  [26—28]. In  fact,  similar  ﬁndings  have  also
een  reported  following  stenting  [29,30]. Moreover,  some
ave  also  suggested  that  a  rigid  segment  of  the  aorta  gener-
ted  by  a  stent  may  lead  to  exercise-induced  hypertension
r girl. The diameter of coarctation is 7.4 mm (A). Notice the small
raphy after implantation of a covered CP stent (CP8Z22) over a 14-
he coarctation site is now 13.5 mm and the aneurysm is completely
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[29]. In  fact,  such  hypertension  is  found  in  about  one  third  of
normotensive  patients  following  either  surgery  or  stenting.
However,  De  Caro  et  al.  [31]  could  not  ﬁnd  any  differ-
ence  between  patients  who  underwent  surgery  or  stenting.
Lastly,  both  post-stenting  and  surgery  patients  have  poorer
left  ventricular  long-axis  function  than  controls,  as  shown
by  tissue  Doppler  imaging,  reﬂecting  subendoendocardium
impairment  [32].
Comparison between stenting and surgery
In  2006,  Carr  published  a  comparison  between  angioplasty
(stent,  balloon  dilatation  or  a  combination;  n  =  633)  and
surgery  (n  =  213)  in  adult  aortic  coarctation  patients,  based
on  papers  published  during  1995—2005  [33]. Stenting  alone
had  the  lowest  morbidity  (mean  9%,  range  0—20%),  while
morbidity  was  slightly  higher  in  the  surgical  group  (mean
11%,  range  0—25%),  mainly  related  to  bleeding  and  recur-
rent  laryngeal  nerve  injury.  Balloon  dilatation  alone  was
associated  with  more  complications  than  stenting  (OR  2.4;
95%  conﬁdence  interval  [CI]  ±  0.8;  relative  risk  [RR]  2.1),
including  traumatic  aneurysm  formation  and  aortic  dissec-
tion.  Restenosis  occurred  in  a  mean  of  11%  (range  0—25%)
in  the  stented  group,  but  in  only  2%  (range  0—9%)  in  the
surgical  group  [33]. Stenting  cured  hypertension  (medi-
cation  free)  in  a  mean  of  61%  of  patients,  compared  to
64%  after  surgery.  These  results  are  clearly  in  favour  of
surgery  for  coarctation  in  the  adult  population.  However,
no  exhaustive  protocol  concerning  hypertension  or  aortic
imaging  could  be  obtained  in  the  follow-up  of  these  surgical
series.
It  is  difﬁcult  to  make  recommendations  because  stent
technology  has  evolved  over  time,  resulting  in  better  stent
designs.  This,  along  with  greater  experience  should  combine
to  give  better  results  with  stents.  Both  surgical  treat-
ment  and  stenting  lack  fundamental  prospective  mid-  and
long-term  follow-up  data  concerning  hypertension  and  arch
anatomy.  Protocols  for  such  studies  should  include  repeated
exercise  studies,  24-hour  ambulatory  blood  pressure  moni-
toring  and  MRI/CT  evaluations.
Since  the  publication  by  Carr  [33], results  of  a  large  non-
randomized  surgical  cohort  have  been  published,  including
404  patients  with  a  follow-up  of  27  years  [34]. The  rate
of  persistent  hypertension  in  this  series  was  57%,  but  with
only  13%  of  patients  with  signiﬁcant  residual  gradient.  The
risk  factors  for  hypertension  included  repair  with  pros-
thetic  material,  male  sex,  residual  gradient  and  older  age
at  follow-up.
In  the  future,  it  may  be  of  interest  to  set  up  a  multicen-
tre  prospective  randomized  clinical  trial  comparing  stenting
angioplasty  and  surgical  repair  to  deﬁne  the  best  form  of
treatment  for  coarctation  of  the  aorta  in  adolescents  and
adults.
Late complicationsPatients  with  coarctation  of  the  aorta  have  a  high  risk  of
late  cardiovascular  morbidity  and  mortality,  mainly  related
to  persistent  systemic  hypertension.  Other  potential  late
complications  include  premature  coronary  artery  disease,
a
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udden  cardiac  death,  heart  failure,  stroke,  recoarctation,
eft  ventricular  outﬂow  tract  obstruction,  major  aneurysm,
upture,  dissection,  endarteritis  and  ﬁstulae  [1].  In  the
xperience  of  Oliver  et  al.  [35], with  a  cohort  of  235
atients  including  those  treated  with  surgery  or  balloon
ngioplasty/stenting  and  those  with  native  coarctation,  16%
xperienced  aortic  wall  complications  during  follow-up,
ncluding  ascending  aortic  aneurysms  (9%)  and  descend-
ng  aortic  aneurysms  (4%).  There  was  no  difference  among
he  three  groups  with  respect  to  the  development  of  aor-
ic  complications.  However,  in  this  population,  57%  had
ssociated  bicuspid  aortic  valve.  Multivariable  analysis  did
ot  reveal  any  signiﬁcant  relationships  between  previ-
us  repair,  type  of  repair,  age  at  repair,  residual  Doppler
radient  or  systemic  hypertension  and  the  occurrence  of
ortic  wall  complications  [35]. In  fact,  only  aging  (RR
.4  per  decade  of  age,  95%  CI  1.1—1.8;  p  =  0.002)  and
resence  of  a  bicuspid  valve  (RR  3.2,  95%  CI  1.3—7.5;
 =  0.00023)  were  signiﬁcantly  associated  with  aortic  wall
omplications  [35]. The  increased  risk  in  patients  with  a
icuspid  aortic  valve  may  result  from  factors  such  as  thinner
lastic  lamellae  of  the  aortic  media  with  greater  distance
etween  lamellae  and  premature  medial  layer  smooth  cell
poptosis  [35].
ollow-up protocol
ong-term  evaluation  of  both  stent  and  aortic  wall
ntegrity  is  essential  to  monitor  potentially  life-threatening
omplications.  Although  MRI  is  considered  to  be  the  gold
tandard  following  surgical  repair  [36], use  of  MRI  follow-
ng  implantation  of  a  stainless  steel  stent  has  been  shown
o  be  relatively  ineffective  due  to  magnetic  susceptibil-
ty  and  metallic  stent  artefact  with  loss  of  signal.  Thus,
T  scanning  is  considered  the  optimal  follow-up  method
o  detect  anatomical  characteristics  such  as  aneurysm
ormation,  intrastent  stenosis,  dissection  and  stent  frac-
ure  [12,22,37]. Usually,  a  contrast-enhanced  aortic  CT
can  is  performed  3—6  months  following  the  procedure,
r  earlier  if  there  is  any  signiﬁcant  procedural  compli-
ation  [22]. However,  radiation  burden  should  not  be
gnored,  especially  if  CT  is  repeated.  Therefore,  Rosen-
hal  and  Bell  [37]  have  proposed  an  alternative  to  CT  using
odern  MRI  sequences,  especially  in  patients  with  plat-
num  stents,  to  decrease  the  cumulative  radiation  burden.
inally,  after  coarctation  stenting,  the  optimal  frequency
f  imaging  should  be  three  to  ﬁve  yearly  in  the  absence
f  intervening  clinical,  echocardiographic  or  radiological
oncerns  [1,6,22].
onclusions
o  conclude,  stent  implantation  is  a  good  alternative  to
urgery  for  the  treatment  of  coarctation  of  the  aorta  in
dolescents  and  adults.  It  is  associated  with  a  low-residual
radient  and  a  low  rate  of  restenosis,  both  immediately  and
t  follow-up.  It  is  effective  in  controlling  systemic  hyper-
ension  and  has  a  relatively  low  incidence  of  complications.
ll  these  results  compare  favourably  with  those  of  surgi-
al  repair,  and  justify  the  present  use  of  primary  stenting
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